Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Reaxon Plus

K-Number: K180222 · 2018-04-24

ApplicantMedovent GmbH
Decision Date2018-04-24
Product CodeJXI
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Reaxon Plus is a medical device manufactured by Medovent GmbH. It received FDA 510(k) clearance on 2018-04-24 under approval number K180222. The device is classified under product code JXI. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Reaxon Plus?

Reaxon Plus is a medical device that received FDA 510(k) clearance on 2018-04-24. It is manufactured by Medovent GmbH. The 510(k) number is K180222.

When was Reaxon Plus approved by the FDA?

Reaxon Plus received FDA 510(k) clearance on 2018-04-24, under approval number K180222.

What company makes Reaxon Plus?

Reaxon Plus is manufactured by Medovent GmbH.

What is the FDA product code for Reaxon Plus?

The FDA product code for Reaxon Plus is JXI.

Related Devices (Code: JXI)

K162741AxoGuard Nerve ConnectorCook Biotech Incorporated K152967NERBRIDGEToyobo Co., Ltd. K152684Nerve Capping DevicePolyganics Innovations BV K163446AxoGen Nerve CapAxogen Corporation K170656Reinforced Flexible Collagen Nerve CuffCollagen Matrix, Inc. K163457NeuraGen 3D Nerve Guide MatrixIntegra LifeSciences Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑